Related Experiment Video
Updated: Jun 24, 2026
12:55
P50 Sensory Gating in Infants
Published on: December 26, 2013
Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications
1MRC SGDP Centre, Institute of Psychiatry, Denmark Hill, London SE5 8AF, United Kingdom. jackie.conway@doctors.org.uk
Medical Hypotheses
|March 31, 2009
Summary
People with schizophrenia smoke more due to nicotine self-medication, which helps sensory gating. This research explores nicotine
Area of Science:
- Neuroscience
- Psychiatry
- Addiction Research
Background:
- Cigarette smoking is widely recognized as detrimental to physical health.
- The relationship between smoking and mental health, particularly schizophrenia, is complex.
- Individuals with schizophrenia exhibit exceptionally high rates of cigarette consumption.
Purpose of the Study:
- To investigate the reasons behind increased cigarette smoking in schizophrenia.
- To understand the role of nicotine in managing schizophrenia symptoms.
- To explore nicotine's potential therapeutic effects in a less toxic form.
Main Methods:
- Review of existing research on smoking patterns in schizophrenia.
- Analysis of neurobiological findings related to nicotine and schizophrenia.
- Hypothesizing the self-medication mechanism involving nicotine and sensory gating.
Main Results:
- Schizophrenia is associated with deficient endogenous central nicotinic neurotransmission.
- This deficiency leads to disrupted sensory gating, potentially causing positive symptoms.
- Increased nicotine intake through smoking appears to alleviate these deficits.
Conclusions:
- Cigarette smoking in schizophrenia may serve as a form of self-medication.
- Nicotine alleviates disrupted sensory gating and may mitigate positive symptoms.
- Further research into therapeutic nicotine delivery for schizophrenia is warranted.
More Related Videos
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
10:48Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...